This site is intended for healthcare professionals
EMC Drug Feed
Drug information

Boots Antiseptic

OTC
Read time: 3 mins
Last updated: 03 Aug 2015

Summary of product characteristics


1. Name of the medicinal product

Boots Antiseptic Cream


2. Qualitative and quantitative composition

Active ingredients

% w/w

2, 4 Dichlorobenzyl alcohol

HSE

0.5%

Cetrimide

EP

0.5%

Allantoin BPC' 34

BPC

0.2%


3. Pharmaceutical form

Cream


4.1. Therapeutic indications

For abrasions, minor burns and scalds, small areas of sunburn, dry chapped skin, nappy rash, insect bites, spots and pimples.


4.2. Posology and method of administration

Adults, Children and Elderly:Apply the cream gently to the affected area two or three times a day.For topical application.


4.3. Contraindications

Hypersensitivity to any of the ingredients.


4.4. Special warnings and precautions for use

Prolonged and repeated applications are inadvisable as hypersensitivity may occur. If symptoms persist, consult your doctor. For external use only. Keep all medicines out of the reach of children.


4.5. Interaction with other medicinal products and other forms of interaction

No clinically significant interactions known.


4.6. Fertility, pregnancy and lactation

The safety of Antiseptic Cream during pregnancy and lactation has not been established, but use during these periods is not considered to constitute a hazard.


4.7. Effects on ability to drive and use machines

Not applicable.


4.8. Undesirable effects

Hypersensitivity reactions may occasionally occur in certain individuals following repeated application.

Reporting of suspected adverse reactions

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard.


4.9. Overdose

Where excessive application has been made to the skin, excess cream should be removed and the area washed with soap and water. Otherwise no further treatment is necessary.In case of ingestion, the product may cause burning and irritation in the mouth and oesophagus. If any treatment is required at all, milk should be given to drink, otherwise symptomatic/supportive therapy should be given.


5.1. Pharmacodynamic properties

Dichlorobenzyl alcohol has antiseptic properties. Cetrimide is a quaternary ammonium antiseptic which has bactericidal activity against both gram positive and gram negative organisms. Allantoin is claimed to stimulate tissue formation and hasten wound healing.


5.2. Pharmacokinetic properties

Not available.


5.3. Preclinical safety data

There are no preclinical data of relevance to the prescriber which are additional to that already included.


6.1. List of excipients

Hyetellose (Hydroxyethyl Cellulose)Cetostearyl AlcoholCeresinLight Liquid ParaffinCetomacrogol 1000Dimethicone 20Polyethylene Glycol 300Perfume Compound AG 8053 CPL Sodium Citrate Granular Anhydrous Citric Acid Granular Purified Water


6.2. Incompatibilities

Not applicable


6.3. Shelf life

24 months


6.4. Special precautions for storage

Do not store above 30°C.


6.5. Nature and contents of container

Internally lacquered collapsible aluminium tube having a membrane seal and cap, in a cardboard carton.

Pack sizes:

15, 20, 25, 30, 35, 40, 50, 60, 75, 80, 100, 120g.

Laminate tube with polypropylene cap in a cardboard carton.

Pack sizes:

15, 20, 25, 30, 35, 40, 50, 60, 75, 80, 100, 120g.

Laminate tube with polypropylene cap and polythene/aluminium membrane seal in a cardboard carton.

Pack sizes:

15, 20, 25, 30, 35, 40, 50, 60, 75, 80, 100, 120g.


6.6. Special precautions for disposal and other handling

Not applicable.


7. Marketing authorisation holder

The Boots Company PLC1 Thane Road WestNottingham NG2 3AA


8. Marketing authorisation number(s)

PL 00014/5138R


9. Date of first authorisation/renewal of the authorisation

Date of First Authorisation:

7 November 1984

Last Renewal:

15 June 2000


10. Date of revision of the text

14 July 2015

4.1 Therapeutic indications

For abrasions, minor burns and scalds, small areas of sunburn, dry chapped skin, nappy rash, insect bites, spots and pimples.

4.2 Posology and method of administration

Adults, Children and Elderly:Apply the cream gently to the affected area two or three times a day.For topical application.

4.3 Contraindications

Hypersensitivity to any of the ingredients.

4.4 Special warnings and precautions for use

Prolonged and repeated applications are inadvisable as hypersensitivity may occur. If symptoms persist, consult your doctor. For external use only. Keep all medicines out of the reach of children.

4.5 Interaction with other medicinal products and other forms of interaction

No clinically significant interactions known.

4.6 Fertility, pregnancy and lactation

The safety of Antiseptic Cream during pregnancy and lactation has not been established, but use during these periods is not considered to constitute a hazard.

4.7 Effects on ability to drive and use machines

Not applicable.

4.8 Undesirable effects

Hypersensitivity reactions may occasionally occur in certain individuals following repeated application.

Reporting of suspected adverse reactions

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard.

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

 

 

Disclaimer

The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC (www.medicines.org.uk/emc/). Medthority offers the whole library of SPC documents from eMC.

Medthority will not be held liable for explicit or implicit errors, or missing data.

Reporting of suspected adverse reactions 

Drug Licencing

Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).